Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) have received an average recommendation of "Moderate Buy" from the six brokerages that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $19.33.
CCAP has been the topic of several recent analyst reports. Keefe, Bruyette & Woods raised their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Monday, November 25th. Wells Fargo & Company boosted their price objective on Crescent Capital BDC from $18.00 to $19.00 and gave the stock an "equal weight" rating in a report on Wednesday, January 29th.
Get Our Latest Stock Report on CCAP
Hedge Funds Weigh In On Crescent Capital BDC
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Ieq Capital LLC grew its stake in Crescent Capital BDC by 2.6% during the 4th quarter. Ieq Capital LLC now owns 22,725 shares of the company's stock worth $437,000 after buying an additional 584 shares during the last quarter. Confluence Investment Management LLC increased its stake in Crescent Capital BDC by 0.9% during the 4th quarter. Confluence Investment Management LLC now owns 73,839 shares of the company's stock worth $1,419,000 after buying an additional 633 shares in the last quarter. HighTower Advisors LLC grew its position in shares of Crescent Capital BDC by 0.5% in the third quarter. HighTower Advisors LLC now owns 141,838 shares of the company's stock valued at $2,624,000 after purchasing an additional 768 shares in the last quarter. Denali Advisors LLC lifted its holdings in Crescent Capital BDC by 0.5% in the fourth quarter. Denali Advisors LLC now owns 183,783 shares of the company's stock valued at $3,532,000 after acquiring an additional 855 shares during the last quarter. Finally, Van ECK Associates Corp lifted its holdings in Crescent Capital BDC by 2.3% in the fourth quarter. Van ECK Associates Corp now owns 45,562 shares of the company's stock valued at $876,000 after acquiring an additional 1,006 shares during the last quarter. Hedge funds and other institutional investors own 49.46% of the company's stock.
Crescent Capital BDC Stock Performance
Shares of CCAP stock traded up $0.09 on Friday, hitting $19.62. The company's stock had a trading volume of 86,130 shares, compared to its average volume of 80,906. Crescent Capital BDC has a fifty-two week low of $15.91 and a fifty-two week high of $20.03. The stock's 50 day moving average is $19.41 and its 200-day moving average is $18.78. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.26 and a current ratio of 1.26. The company has a market capitalization of $727.12 million, a PE ratio of 7.69 and a beta of 0.81.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.64 EPS for the quarter, topping analysts' consensus estimates of $0.57 by $0.07. The firm had revenue of $51.63 million during the quarter, compared to analysts' expectations of $48.76 million. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. During the same quarter in the prior year, the business earned $0.59 earnings per share. Equities research analysts expect that Crescent Capital BDC will post 2.43 earnings per share for the current fiscal year.
Crescent Capital BDC Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st were given a dividend of $0.42 per share. The ex-dividend date was Tuesday, December 31st. This represents a $1.68 annualized dividend and a dividend yield of 8.56%. This is a boost from Crescent Capital BDC's previous quarterly dividend of $0.07. Crescent Capital BDC's dividend payout ratio (DPR) is currently 65.88%.
Crescent Capital BDC Company Profile
(
Get Free ReportCrescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also

Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.